These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors. Je EM; Yoo NJ; Kim YJ; Kim MS; Lee SH Int J Cancer; 2013 Jul; 133(1):260-5. PubMed ID: 23280334 [TBL] [Abstract][Full Text] [Related]
3. Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance. Patnaik MM; Lasho TL; Finke CM; Hanson CA; Hodnefield JM; Knudson RA; Ketterling RP; Pardanani A; Tefferi A Am J Hematol; 2013 Mar; 88(3):201-6. PubMed ID: 23335386 [TBL] [Abstract][Full Text] [Related]
4. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Makishima H; Visconte V; Sakaguchi H; Jankowska AM; Abu Kar S; Jerez A; Przychodzen B; Bupathi M; Guinta K; Afable MG; Sekeres MA; Padgett RA; Tiu RV; Maciejewski JP Blood; 2012 Apr; 119(14):3203-10. PubMed ID: 22323480 [TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts. Kang MG; Kim HR; Seo BY; Lee JH; Choi SY; Kim SH; Shin JH; Suh SP; Ahn JS; Shin MG BMC Cancer; 2015 Jun; 15():484. PubMed ID: 26115659 [TBL] [Abstract][Full Text] [Related]
6. Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML. Hirabayashi S; Flotho C; Moetter J; Heuser M; Hasle H; Gruhn B; Klingebiel T; Thol F; Schlegelberger B; Baumann I; Strahm B; Stary J; Locatelli F; Zecca M; Bergstraesser E; Dworzak M; van den Heuvel-Eibrink MM; De Moerloose B; Ogawa S; Niemeyer CM; Wlodarski MW; Blood; 2012 Mar; 119(11):e96-9. PubMed ID: 22238327 [TBL] [Abstract][Full Text] [Related]
7. Splicing Factor Mutations in Cancer. Bejar R Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388 [TBL] [Abstract][Full Text] [Related]
8. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia. Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291 [TBL] [Abstract][Full Text] [Related]
9. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors. Scott LM; Rebel VI J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622 [TBL] [Abstract][Full Text] [Related]
10. Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy. Hahn CN; Venugopal P; Scott HS; Hiwase DK Immunol Rev; 2015 Jan; 263(1):257-78. PubMed ID: 25510282 [TBL] [Abstract][Full Text] [Related]
11. Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies. Taylor J; Lee SC Genes Chromosomes Cancer; 2019 Dec; 58(12):889-902. PubMed ID: 31334570 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome. Hong JY; Seo JY; Kim SH; Jung HA; Park S; Kim K; Jung CW; Kim JS; Park JS; Kim HJ; Jang JH Anticancer Res; 2015 May; 35(5):3081-9. PubMed ID: 25964599 [TBL] [Abstract][Full Text] [Related]
14. Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations. Jeromin S; Haferlach T; Weissmann S; Meggendorfer M; Eder C; Nadarajah N; Alpermann T; Kohlmann A; Kern W; Haferlach C; Schnittger S Haematologica; 2015 Apr; 100(4):e125-7. PubMed ID: 25527566 [No Abstract] [Full Text] [Related]
15. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations. Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861 [TBL] [Abstract][Full Text] [Related]
17. Effect of RNA splicing machinery gene mutations on prognosis of patients with MDS: A meta-analysis. Wang X; Song X; Yan X Medicine (Baltimore); 2019 May; 98(21):e15743. PubMed ID: 31124956 [TBL] [Abstract][Full Text] [Related]
18. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Przychodzen B; Jerez A; Guinta K; Sekeres MA; Padgett R; Maciejewski JP; Makishima H Blood; 2013 Aug; 122(6):999-1006. PubMed ID: 23775717 [TBL] [Abstract][Full Text] [Related]
19. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Cazzola M; Rossi M; Malcovati L; Blood; 2013 Jan; 121(2):260-9. PubMed ID: 23160465 [TBL] [Abstract][Full Text] [Related]
20. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast. Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]